Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00281008
Recruitment Status : Completed
First Posted : January 24, 2006
Last Update Posted : August 3, 2016
Ionis Pharmaceuticals, Inc.
Information provided by:
Kastle Therapeutics, LLC

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2007
  Actual Study Completion Date : December 2007